Ultrasound First for Removal of Nonpalpable Contraceptive Implants.
Journal
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
ISSN: 1550-9613
Titre abrégé: J Ultrasound Med
Pays: England
ID NLM: 8211547
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
15
09
2020
accepted:
18
09
2020
pubmed:
25
10
2020
medline:
20
7
2021
entrez:
24
10
2020
Statut:
ppublish
Résumé
The Sound Judgment Series consists of invited articles highlighting the clinical value of using ultrasound first in specific clinical diagnoses where ultrasound has shown comparative or superior value. The series is meant to serve as an educational tool for medical and sonography students and clinical practitioners and may help integrate ultrasound into clinical practice.
Substances chimiques
Contraceptive Agents
0
Drug Implants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1479-1483Informations de copyright
© 2020 American Institute of Ultrasound in Medicine.
Références
Centers for Disease Control and Prevention. Current contraceptive status among women aged 15-49: United States, 2015-2017. Centers for Disease Control and Prevention website. https://www.cdc.gov/nchs/products/databriefs/db327.htm. Accessed May 24, 2020.
Food and Drug Administration. Highlights of prescribing information of Implanon (etonogestrel implant 68 mg). Food and Drug administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021529s018lbl.pdf. Accessed May 24,2020.
Lefebvre R, Hom M, Leland H, Stevanovic M. Peripheral nerve injury with Nexplanon removal: case report and review of the literature. Contracept Reprod Med 2018; 3:15.
Levine JP, Sinofsky FE, Christ MF. Assessment of Implanon insertion and removal. Contraception 2008; 78:409-417.
Mommers E, Blum GF, Gent TG, Peters KP, Sørdal TS, Marintcheva-Petrova M. Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial. Am J Obstet Gynecol 2012; 207:388.e1-388.e6.
Merki-Feld GS, Brekenfeld C, Migge B, Keller PJ. Nonpalpable ultrasonographically not detectable Implanon rods can be localized by magnetic resonance imaging. Contraception 2001; 63:325-328.
Vollans SR, Grainger A, O'Connor P, Limb D. Hormone-releasing contraceptive implants: our experience of complex removals using preoperative ultrasound. Contraception 2015; 92:81-83.
Kang S, Niak A, Gada N, Brinker A, Jones SC. Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database. Contraception 2017; 96:439-445.
Pymar HC, Creinin MD, Schwartz JL. “Pop-out” method of levonorgestrel implant removal. Contraception 1999; 59:383-387.
Chen MJ, Creinin MD. Removal of a nonpalpable etonogestrel implant with preprocedure ultrasonography and modified vasectomy clamp. Obstet Gynecol 2015; 126:935-938.
Inserting and removing levonorgestrel subdermal implants: an update. Contracept Rep 1994; 5:4-12.
Nouri K, Pinker-Domenig K, Ott J, Fraser I, Egarter C. Removal of non-palpable Implanon with the aid of a hook-wire marker. Contraception 2013; 88:577-580.
Chung M, Loudill C, Wieler M, Farnam J, Ahn SH. Endovascular retrieval of Nexplanon from the distal pulmonary artery. J Vasc Interv Radiol 2017; 28:466-467.
Pillai M. Ultrasound-guided hydrodissection for removal of precariously sited contraceptive implants. BMJ Sex Reprod Health 2018; 44:303-306.
Nexplanon. Nexplanon (etonorgestrel implant) 68 mg radiopaque. Nexplanon product website. https://www.nexplanon.com/?src=google&med=cpc&camp=Nexplanon_+NexplanonEXCT_BRND_NA_ENGM_EXCT_TEXT_FEMALE&adgrp=Nexplanon+-+Exact&kw=nexplanon&utm_kxconfid=sgaizzyx0&gclid=CjwKCAjwtqj2BRBYEiwAqfzur9wxCy6gGZN9qU46-2ptiIuz3nMgMvPtE8EFV-D2S4YWGtNsoafdcRoCe_sQAvD_BwE&gclsrc=aw.ds. Accessed May 24, 2020.